Cargando…

The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma

Detalles Bibliográficos
Autores principales:	Isaksen, Kathrine T., Beiske, Klaus, Smeland, Erlend B., Jørgensen, Judit, Brodtkorb, Marianne, Myklebust, June Helen, Jerkeman, Mats, Meriranta, Leo, Karjalainen‐Lindsberg, Marja‐Liisa, Leppä, Sirpa, Scott, David W., Holte, Harald, Blaker, Yngvild Nuvin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175840/ https://www.ncbi.nlm.nih.gov/pubmed/35846101 http://dx.doi.org/10.1002/jha2.109

Ejemplares similares

Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
por: Autio, Matias, et al.
Publicado: (2020)

A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL
por: Isaksen, Kathrine T., et al.
Publicado: (2021)

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
por: Ludvigsen, Maja, et al.
Publicado: (2023)

T026: Characterization of cancer-associated fibroblasts in classical Hodgkin lymphoma
por: Karihtala, Kristiina, et al.
Publicado: (2022)

Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
por: Taskinen, Minna, et al.
Publicado: (2014)

Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment
por: Autio, Matias, et al.
Publicado: (2022)

Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma
por: Karihtala, Kristiina, et al.
Publicado: (2020)

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma
por: Leivonen, S-K, et al.
Publicado: (2017)

Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients
por: Karihtala, Kristiina, et al.
Publicado: (2022)

The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy
por: Isaksen, Kathrine T., et al.
Publicado: (2023)

Low lymphocyte‐to‐monocyte ratio predicts poor outcome in high‐risk aggressive large B‐cell lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2022)

Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study
por: Pauly, F, et al.
Publicado: (2016)

T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma
por: Leivonen, Suvi-Katri, et al.
Publicado: (2019)

Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas
por: Leivonen, Suvi-Katri, et al.
Publicado: (2023)

MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma
por: Leivonen, Suvi-Katri, et al.
Publicado: (2017)

Identification of Highly Methylated Genes across Various Types of B-Cell Non-Hodgkin Lymphoma
por: Bethge, Nicole, et al.
Publicado: (2013)

PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma
por: Pollari, Marjukka, et al.
Publicado: (2018)

Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma
por: Bethge, Nicole, et al.
Publicado: (2014)

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R-POLA-MINI-CHP AND R-MINI-CHOP
por: Jerkeman, Mats, et al.
Publicado: (2023)

Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021)

Evaluation of Memorial Sloan‐Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma
por: Jahr, Guro, et al.
Publicado: (2018)

Testicular Diffuse Large B-Cell Lymphoma—Clinical, Molecular, and Immunological Features
por: Pollari, Marjukka, et al.
Publicado: (2021)

New indications and platforms for CAR‐T therapy in lymphomas beyond DLBCL
por: Iqbal, Madiha, et al.
Publicado: (2021)

Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.
por: Stokke, T., et al.
Publicado: (1998)

A Gene Panel, Including LRP12, Is Frequently Hypermethylated in Major Types of B-Cell Lymphoma
por: Bethge, Nicole, et al.
Publicado: (2014)

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
por: Harrysson, Sara, et al.
Publicado: (2021)

Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specified
por: Itami, Hiroe, et al.
Publicado: (2021)

Advancing the management of double hit lymphoma
por: Landsburg, Daniel J.
Publicado: (2017)

Drug therapy for double-hit lymphoma
por: Phuoc, Vania, et al.
Publicado: (2019)

Modified conditioning regimen with chidamide and high‐dose rituximab for triple‐hit lymphoma
por: Kang, Junnan, et al.
Publicado: (2021)

Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.
por: Stokke, T., et al.
Publicado: (1998)

Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study
por: Kalashnikov, Ilja, et al.
Publicado: (2023)

Mantle cell lymphoma with features of marginal-zone lymphoma
por: Randen, Ulla, et al.
Publicado: (2011)

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021)

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
por: Zhang, Wenqi, et al.
Publicado: (2021)

Lymphoma Microenvironment in DLBCL and PTCL-NOS: the key to uncovering heterogeneity and the potential for stratification
por: Miyawaki, Kohta, et al.
Publicado: (2022)

Diffuse Large B-Cell Lymphoma (DLBCL) in an Aged Raccoon (Procyon lotor)
por: D’Annunzio, Giulia, et al.
Publicado: (2022)

Role of Smad Proteins in Resistance to BMP-Induced Growth Inhibition in B-Cell Lymphoma
por: Huse, Kanutte, et al.
Publicado: (2012)

Educational Case: Gastric High-Grade B-Cell Lymphoma With MYC and BCL2 Gene Rearrangement (Double-Hit Lymphoma)
por: Betts, Elham Vali, et al.
Publicado: (2020)

Transformation and outcome of nodular lymphocyte predominant Hodgkin lymphoma: a Finnish Nationwide population-based study
por: Kalashnikov, Ilja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a6ihgh1idrsv9ubcgccr04vd7t